Ultraviolet (UV) radiation is known to be an important etiologic agent in the development of skin cancer. Keratoacanthoma is an unusual, well-described cutaneous neoplasm that resembes squamous cell carcinoma but spontaneously resolves. Rarely, multiple keratoacanthomas may develop. Objective We present a case of multiple keratoacanthomas in a patient with psoriasis who had received UVB phototherapy. These lesions were hyperkeratotic papules, many of which spontaneously resolved and demonstrated the histologic characteristics of keratoacanthoma.
Conclusion:
We believe that UV radiation is the most likely etiologic factor in this patient's development of multiple keratoacanthomas. We wish to bring to the attention of clinicians this unusual adverse effect of UV treatment.
Get full access to this article
View all access options for this article.
References
1.
HönigsmannH. Phototherapy for psoriasisClin Exp Dermatol2001; 26:343–350.
2.
McClureSLValentineJGordonKB. Comparative Tolerability of systemic treatments for plaque-type psoriasisDrug Saf2002; 25:913–927.
3.
LaubeSGeorgeSA. Adverse effects with PUVA and UVB phototherapyJ Dermatol Treat2001; 12:101–105.
4.
HobbsJLebwohlMLimHW. Improving the safety profile of long-term PUVA therapyJ Am Acad Dermatol1999; 41:496–497.
5.
SternRSLairdN. The carcinogenic risk of treatments for severe psoriasisCancer1994; 73:2759–2764.
6.
StudnibergHMWellerP. PUVA, UVB, psoriasis, and nonmelanoma skin cancerJ Am Acad Dermatol1993; 29:1013–1022.
7.
GasparroFP. The role of PUVA in the treatment of psoriasis: Photobiology issues related to skin cancer incidenceAm J Clin Dermatol2000; 1:337–348.
8.
MomtazKFitzpatrickTB. The benefits and risks of long-term PUVA photochemotherapyDermatol Clin1998; 16:227–234.
9.
SternRSNicholsKTVaekevaeLH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA)N Engl J Med1997; 108:897–900.
10.
SchwartzRA. KeratoacanthomaJ Am Acad Dermatol1994; 30:1–19.
11.
BehamARegauerSSoyerHP. Keratoacanthoma: A clinically distinct variant of well differentiated squamous cell carcinomaAdv Anat Pathol1998; 5:269–280.
12.
SchwartzRA. The keratoacanthoma: A reviewJ Surg Oncol1979; 12:305–317.
13.
SchwartzRABlaszczykMJablonskaS. Generalized eruptive keratoacanthoma of Grzybowski: Follow-up of the original description and 50-year retrospectDermatol2002; 205:348–352.
14.
MaddinWSWoodWS. Multiple keratoacanthomas and squamous cell carcinomas occurring at psoriatic treatment sitesJ Cutan Pathol1979; 6:96–100.
15.
KavanaghGMMarshmannGHannaMM. A case of Grzybowski's generalized eruptive keratoacanthomasAustralas J Dermatol1995; 36:83–85.
AnnamalaiRVasanthaMUmaselvamM. Multiple keratoacanthoma and squamous cell carcinoma in psoriasisInt J Dermatol1981; 20:606–607.
19.
SinaBAdrianRM. Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A photochemotherapyJ Am Acad Dermatol1983; 9:686–688.
20.
WeisntockMACoulterSBatesJ. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapyArch Dermatol1995; 131:701–704.
21.
AltmanJSAdlerSS. Development of multiple cutaneous squamous cell carcinomas during PUVA treatment for chronic graft-versus-host diseaseJ Am Acad Dermatol1994; 31:505–507.
22.
PenmetchaMHighetASHopkinsonJM. Failure of PUVA in lichen myxoedematosus: Acceleration of associated multiple keratoacanthomas with development of squamous carcinomaClin Exp Dermatol1987; 12:220–223.
TennstedtDLachapelleJM. Keratoacanthoma et xeroderma pigmentosumAnn Dermatol Venereol1977; 104:98–102.
25.
ChampionRHRookA. Keratoacanthoma In: PillsburyDMLivingoodCS, Proceedings of the 12th International Congress of Dermatology, vol 1Amsterdam: Excerpta Medica, 1963; pp 288–291.
